INmune Bio's XPro missed its Phase II primary endpoint, but subgroup data and safety profile suggest potential for targeted Alzheimer's patients with neuroinflammation. Despite the setback, I see ...
The government has established a concrete strategy to secure artificial intelligence (AI) technology, which has emerged as a game changer in the bio field. On the 30th, the Ministry of Science and ICT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback